The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion

Abstract

The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple gestations, though these studies have important limitations. Earn online CME credit related to this document at www.asrm.org/elearn